Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins.

We have tested a hypothesis that aggregates of modified low density lipoproteins (LDL) play the key role in the accumulation of lipids by cells of unaffected aortic intima. It was demonstrated using analysis of relative dispersion of light transmission fluctuations as well as gel filtration on Sepharose CL-2B that LDL modified by oxidation, glycosylation, desialylation and malondialdehyde treatment form aggregates under the conditions of culture. Native LDL failed to aggregate under the same conditions. It was demonstrated that modified LDL, unlike native LDL, bring about a 2- to 3-fold rise in cholesteryl ester levels of cultured cells. Moreover, direct and strong correlation (r = 0.86) was observed between the degree of lipoprotein aggregation and the amount of cholesteryl esters accumulated. Removal of modified LDL aggregates by filtration through a 0.1 micron filter or gel filtration completely prevented the intracellular accumulation of cholesteryl esters. These findings indicate that LDL aggregates play an essential, if not the decisive, role in the intracellular accumulation of lipids in vitro.

[1]  G. Schonfeld.  Lipoproteins in atherogenesis. , 1979, Artery.

[2]  J. Morrisett,et al.  Quantitation, isolation, and characterization of human lipoprotein (a). , 1986, Methods in enzymology.

[3]  R. Mahley,et al.  Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. , 1978, The Journal of biological chemistry.

[4]  N S Radin,et al.  Lipid extraction of tissues with a low-toxicity solvent. , 1978, Analytical biochemistry.

[5]  G. Cazzolato,et al.  Presence of a Modified Low Density Lipoprotein in Humans , 1988, Arteriosclerosis.

[6]  H. J. Kim,et al.  Nonenzymatic glycosylation of human plasma low density lipoprotein. Evidence for in vitro and in vivo glucosylation. , 1982, Metabolism: clinical and experimental.

[7]  P. Edwards,et al.  The metabolism of native and malondialdehyde-altered low density lipoproteins by human monocyte-macrophages. , 1981, Journal of lipid research.

[8]  B. Lewis,et al.  Flux of plasma lipoproteins into human arterial intima. Comparison between grossly normal and atheromatous intima. , 1981, Atherosclerosis.

[9]  D. Leake,et al.  Lipid accumulation in arterial smooth muscle cells in culture. Morphological and biochemical changes caused by low density lipoproteins and chloroquine. , 1982, Atherosclerosis.

[10]  V. Tertov,et al.  Association of low-density lipoprotein with particulate connective tissue matrix components enhances cholesterol accumulation in cultured subendothelial cells of human aorta. , 1987, Biochimica et biophysica acta.

[11]  S. Srinivasan,et al.  Complexes of low-density lipoproteins and arterial proteoglycan aggregates promote cholesteryl ester accumulation in mouse macrophages. , 1985, Biochimica et biophysica acta.

[12]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[13]  H. Shio,et al.  Lipoprotein-heparin-fibronectin-denatured collagen complexes enhance cholesteryl ester accumulation in macrophages , 1984, The Journal of cell biology.

[14]  V. Trieu,et al.  Interactions of low density lipoprotein2 and other apolipoprotein B-containing lipoproteins with lipoprotein(a). , 1988, The Journal of biological chemistry.

[15]  J. Ziegenhorn,et al.  Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. , 1983, Clinical chemistry.

[16]  R. Mahley,et al.  Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective chemical modification of lysine residues of the apoproteins. , 1979, The Journal of clinical investigation.

[17]  E. B. Smith,et al.  The relationship between plasma and tissue lipids in human atherosclerosis. , 1974, Advances in lipid research.